Your browser doesn't support javascript.
loading
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.
Kawai, Hidetsugu; Ando, Kiyoshi; Maruyama, Dai; Yamamoto, Kazuhito; Kiyohara, Eiji; Terui, Yasuhito; Fukuhara, Noriko; Miyagaki, Tomomitsu; Tokura, Yoshiki; Sakata-Yanagimoto, Mamiko; Igarashi, Tadahiko; Kuroda, Junya; Fujita, Jiro; Uchida, Toshiki; Ishikawa, Takayuki; Yonekura, Kentaro; Kato, Koji; Nakanishi, Tadashi; Nakai, Kenya; Matsunaga, Risa; Tobinai, Kensei.
Afiliação
  • Kawai H; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Ando K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Maruyama D; Department of Hematology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
  • Yamamoto K; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Kiyohara E; Department of Dermatology, Osaka University Hospital, Osaka, Japan.
  • Terui Y; Department of Hematology Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Fukuhara N; Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Miyagaki T; Department of Dermatology, The University of Tokyo Hospital, Tokyo, Japan.
  • Tokura Y; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Sakata-Yanagimoto M; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
  • Igarashi T; Department of Hematology, Gunma Cancer Center, Ota, Japan.
  • Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Fujita J; Department of Dermatology, Osaka University Hospital, Osaka, Japan.
  • Uchida T; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yonekura K; Department of Dermatology, Imamura General Hospital, Kagoshima, Japan.
  • Kato K; Department of Hematology and Oncology, Kyushu University Hospital, Fukuoka, Japan.
  • Nakanishi T; Eisai Co., Ltd., Tokyo, Japan.
  • Nakai K; Eisai Co., Ltd., Tokyo, Japan.
  • Matsunaga R; Eisai Co., Ltd., Tokyo, Japan.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Cancer Sci ; 112(6): 2426-2435, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33792128
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article